Lv41
590 积分 2024-08-06 加入
Validation and modification of renal risk score for prediction of long-term kidney survival in patients with MPO-ANCA-associated glomerulonephritis
2小时前
待确认
EE63 Cost-Effectiveness and Budget Impact of Pembrolizumab Monotherapy As the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 ≥ 50% in Thailand
2个月前
已完结
Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for Resectable Non-small Cell Lung Cancer: a Systematic Review and Network Meta-analysis
2个月前
已完结
Optimum immunotherapy method according to PD-L1 expression in advanced lung cancer: a network meta-analysis
2个月前
已完结
Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis
3个月前
已完结
Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis
3个月前
已完结
Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review
3个月前
已完结
Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis
3个月前
已完结
皖公网安备34019202002308
